𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma

✍ Scribed by David P. Ryan; Matthew H. Kulke; Charles S. Fuchs; Michael L. Grossbard; Steven R. Grossman; Jeffrey A. Morgan; Craig C. Earle; Ramesh Shivdasani; Haesook Kim; Robert J. Mayer; Jeffrey W. Clark

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
87 KB
Volume
94
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of gemcitabine and doce
A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma
✍ Barbara J. Gitlitz; Carole Baker; Yvonne Chapman; Heather J. Allen; Linda D. Bos πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objectives of the current study were to evaluate the safety and efficacy of gemcitabine plus docetaxel in patients with unresectable (Stage T4 or β‰₯ N1) metastatic or locally advanced transitional cell carcinoma (TCC) of the urothelial tract. ## METHODS A total of 27

A phase I study of gemcitabine and docet
A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors
✍ David P. Ryan; Thomas J. Lynch; Michael L. Grossbard; Michael V. Seiden; Charles πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

A Phase I study was initiated to determine the maximum tolerated dose of weekly gemcitabine combined with monthly, fixed-dose docetaxel. ## METHODS. Patients with metastatic solid tumors were treated with docetaxel, 60 mg/m 2 , on Day 1 every 28 days. Gemcitabine was administered on Days 1, 8, and

A Phase II trial of docetaxel and estram
A Phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma
✍ Amy D. Tiersten; Caron Nelsen; Susan Talbot; Linda Vahdat; Robert Fine; Andrea T πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The similarity between the mechanism of action between docetaxel and estramustine generated the hypothesis of synergistic antimicrotubule effects and cytotoxicity when the two agents are combined. In addition, it has been demonstrated that estramustine binds P‐glycoprotei